JP2014520075A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014520075A5 JP2014520075A5 JP2014509829A JP2014509829A JP2014520075A5 JP 2014520075 A5 JP2014520075 A5 JP 2014520075A5 JP 2014509829 A JP2014509829 A JP 2014509829A JP 2014509829 A JP2014509829 A JP 2014509829A JP 2014520075 A5 JP2014520075 A5 JP 2014520075A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- formula
- pharmaceutically acceptable
- salt
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 150000001875 compounds Chemical class 0.000 claims 26
- 150000003839 salts Chemical class 0.000 claims 16
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 13
- 238000004519 manufacturing process Methods 0.000 claims 8
- 239000002904 solvent Substances 0.000 claims 8
- 239000003054 catalyst Substances 0.000 claims 5
- 229910052751 metal Inorganic materials 0.000 claims 4
- 239000002184 metal Substances 0.000 claims 4
- 150000001412 amines Chemical class 0.000 claims 2
- 238000006243 chemical reaction Methods 0.000 claims 2
- 238000010511 deprotection reaction Methods 0.000 claims 2
- 239000003446 ligand Substances 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 230000007935 neutral effect Effects 0.000 claims 2
- 230000002829 reductive effect Effects 0.000 claims 2
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 229910052796 boron Inorganic materials 0.000 claims 1
- 239000003638 chemical reducing agent Substances 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 claims 1
- 238000009901 transfer hydrogenation reaction Methods 0.000 claims 1
- 230000007704 transition Effects 0.000 claims 1
- 229910052723 transition metal Inorganic materials 0.000 claims 1
- 150000003624 transition metals Chemical class 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1107985.2A GB201107985D0 (en) | 2011-05-13 | 2011-05-13 | Process |
| GB1107985.2 | 2011-05-13 | ||
| PCT/GB2012/051037 WO2012156693A1 (en) | 2011-05-13 | 2012-05-11 | Process |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014520075A JP2014520075A (ja) | 2014-08-21 |
| JP2014520075A5 true JP2014520075A5 (enExample) | 2015-07-02 |
Family
ID=44260448
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014509829A Withdrawn JP2014520075A (ja) | 2011-05-13 | 2012-05-11 | 方法 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US20140364601A1 (enExample) |
| EP (1) | EP2707362A1 (enExample) |
| JP (1) | JP2014520075A (enExample) |
| KR (1) | KR20140045380A (enExample) |
| CN (1) | CN103649060A (enExample) |
| AU (1) | AU2012257630A1 (enExample) |
| BR (1) | BR112013028789A2 (enExample) |
| CA (1) | CA2835237A1 (enExample) |
| GB (1) | GB201107985D0 (enExample) |
| IL (1) | IL229126A0 (enExample) |
| MX (1) | MX2013012484A (enExample) |
| RU (1) | RU2013148907A (enExample) |
| SG (1) | SG194631A1 (enExample) |
| WO (1) | WO2012156693A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO3192B1 (ar) | 2011-09-06 | 2018-03-08 | Novartis Ag | مركب بنزوثيازولون |
| CN103193658A (zh) * | 2013-04-18 | 2013-07-10 | 苏州永健生物医药有限公司 | 一种（r）-2-对硝基苯乙胺基-1-苯乙醇及其盐的合成方法 |
| TW201615642A (zh) * | 2014-06-02 | 2016-05-01 | 伊史帝夫博士實驗室股份有限公司 | 具有多重模式抗疼痛活性的１－氧雜－４，９－二氮雜螺十一烷化合物之醯胺衍生物 |
| TWI685497B (zh) | 2014-06-02 | 2020-02-21 | 西班牙商伊史帝夫製藥公司 | 具有多重模式抗疼痛活性的１-氧雜-４,９-二氮雜螺十一烷化合物之烷基衍生物 |
| HUE060275T2 (hu) | 2015-11-16 | 2023-02-28 | Esteve Pharmaceuticals Sa | Hatóanyaggal való visszaélés és addikció kezelésére alkalmas oxadiazaspiro-vegyületek |
| SI3697795T1 (sl) | 2017-10-17 | 2024-05-31 | Acondicionamiento Tarrasense | Soli (r)-9-(2,5-difluorofenetil)-4-etil-2-metil-1-oksa-4,9-diazaspiro(5.5) undekan-3-ona |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU745855B2 (en) | 1998-02-02 | 2002-04-11 | Lg Chemical Ltd. | Farnesyl transferase inhibitors having a piperidine structure and process for preparation thereof |
| GB0218629D0 (en) * | 2002-08-09 | 2002-09-18 | Novartis Ag | Organic compounds |
| AR040962A1 (es) | 2002-08-09 | 2005-04-27 | Novartis Ag | Compuestos derivados de tiazol 1,3-2-ona, composicion farmaceutica y proceso de preparacion del compuesto |
| TW200738659A (en) | 2005-08-29 | 2007-10-16 | Astrazeneca Ab | Novel compounds |
| CN101300239A (zh) * | 2005-08-29 | 2008-11-05 | 阿斯利康(瑞典)有限公司 | 作为β2肾上腺素受体激动剂的7-（2-氨基-1-羟基-乙基）-4-羟基苯并噻唑-2(3H)-酮衍生物 |
| PL2242759T3 (pl) * | 2008-02-06 | 2013-06-28 | Astrazeneca Ab | Związki |
-
2011
- 2011-05-13 GB GBGB1107985.2A patent/GB201107985D0/en not_active Ceased
-
2012
- 2012-05-11 AU AU2012257630A patent/AU2012257630A1/en not_active Abandoned
- 2012-05-11 WO PCT/GB2012/051037 patent/WO2012156693A1/en not_active Ceased
- 2012-05-11 SG SG2013079363A patent/SG194631A1/en unknown
- 2012-05-11 US US14/117,259 patent/US20140364601A1/en not_active Abandoned
- 2012-05-11 CN CN201280034581.XA patent/CN103649060A/zh active Pending
- 2012-05-11 RU RU2013148907/04A patent/RU2013148907A/ru not_active Application Discontinuation
- 2012-05-11 BR BR112013028789A patent/BR112013028789A2/pt not_active IP Right Cessation
- 2012-05-11 KR KR1020137032749A patent/KR20140045380A/ko not_active Withdrawn
- 2012-05-11 MX MX2013012484A patent/MX2013012484A/es not_active Application Discontinuation
- 2012-05-11 CA CA2835237A patent/CA2835237A1/en not_active Abandoned
- 2012-05-11 EP EP12722808.8A patent/EP2707362A1/en not_active Withdrawn
- 2012-05-11 JP JP2014509829A patent/JP2014520075A/ja not_active Withdrawn
-
2013
- 2013-10-28 IL IL229126A patent/IL229126A0/en unknown
-
2015
- 2015-09-17 US US14/857,254 patent/US20160002261A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014520075A5 (enExample) | ||
| JP2013518910A5 (enExample) | ||
| AU2014220735B2 (en) | Vortioxetine manufacturing process | |
| Luo et al. | Asymmetric ring-opening of oxabenzonorbornadiene with amines promoted by a chiral iridium-monophosphine catalyst | |
| JP2015507023A5 (enExample) | ||
| CN102241566B (zh) | 一种二苯甲醇及其衍生物的制备方法 | |
| CN103433076A (zh) | 一种固载型不对称催化剂及其在不对称氢化反应中的应用 | |
| CN109320489A (zh) | 一种色烷类化合物及其制备方法 | |
| JP2013100237A5 (enExample) | ||
| JP2013166728A (ja) | アセンジカルコゲノフェン誘導体用中間体及びその合成方法 | |
| JP2013234194A5 (enExample) | ||
| WO2012164242A8 (en) | Process for the preparation of paliperidone | |
| JP2010132661A5 (enExample) | ||
| CN103157513A (zh) | 一种铝络合共轭微孔高分子催化剂及其制备和应用 | |
| CN102942500B (zh) | 一种n-甲酰胺类化合物的制备方法 | |
| JP2015508069A5 (enExample) | ||
| CN103450161A (zh) | 一种化合物zhangshuhua2及原位合成方法 | |
| JP2007045816A5 (ja) | カルバゾール誘導体、発光素子用材料として用いられるアントラセン誘導体の作製方法 | |
| CN108948055A (zh) | 一种8-甲基喹啉偕二硼化合物及其制备方法 | |
| CN104327106B (zh) | 高位阻芳基硼酸酯类化合物的制备方法 | |
| CN103804342A (zh) | 一种胡椒乙酸的制备方法 | |
| CN106748805B (zh) | 一种胺的烷基化方法 | |
| CN103420857A (zh) | 一种具有金刚烷基的季铵盐的制备方法 | |
| CN103435506A (zh) | 一种具有金刚烷基的季铵盐的制备方法 | |
| JP2012513391A5 (enExample) |